1. Home
  2. KBR vs SHC Comparison

KBR vs SHC Comparison

Compare KBR & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KBR Inc.

KBR

KBR Inc.

HOLD

Current Price

$35.99

Market Cap

4.8B

Sector

Industrials

ML Signal

HOLD

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$15.42

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBR
SHC
Founded
1901
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.4B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
KBR
SHC
Price
$35.99
$15.42
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$52.43
$20.33
AVG Volume (30 Days)
1.2M
2.6M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
1.83%
N/A
EPS Growth
15.05
68.75
EPS
3.21
0.27
Revenue
$5,767,000,000.00
$1,163,617,000.00
Revenue This Year
$4.56
$7.51
Revenue Next Year
$5.11
$6.00
P/E Ratio
$11.21
$57.59
Revenue Growth
2.27
5.74
52 Week Low
$34.75
$10.80
52 Week High
$56.78
$19.85

Technical Indicators

Market Signals
Indicator
KBR
SHC
Relative Strength Index (RSI) 42.57 50.79
Support Level $35.91 $15.19
Resistance Level $38.34 $16.55
Average True Range (ATR) 0.95 0.40
MACD 0.01 -0.02
Stochastic Oscillator 43.66 20.57

Price Performance

Historical Comparison
KBR
SHC

About KBR KBR Inc.

KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 36,000 people. The firm generated $7.8 billion in revenue in 2025.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

Share on Social Networks: